95260 ⎘
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS
#3302Aromatic heterocyclic compounds and their application in pharmaceuticals
#3303Chromene derivatives as inhibitors of TCR-Nck interaction
#3304Phenazine derivatives as anti-neoplastic agents and anti-infective agents
#3305Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#3306Opioid receptor ligands and methods of using and making same
#3307Tetrazolinone compound and use thereof
#3308SUBSTITUTED BENZENE COMPOUNDS
#3309Sulfonamide derivative and pharmaceutical use thereof
#3310Pyridic ketone derivatives, method of preparing same, and pharmaceutical application thereof
#3311Condensed cyclic compound and organic light-emitting device including the same
#3312Therapeutic compounds and uses thereof
#3313Deoxycytidine kinase inhibitors
#33141-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof
#3315Inhibition of OLIG2 activity
#3316Hydrochloride salt form for EZH2 inhibition
#3317SUBSTITUTED PHENYLALANINE DERIVATIVES
#3318HETEROCYCLIC SUBSTITUTED TRIFLUOROMETHYL PYRIMIDINONES AND THEIR USE
#3319SUBSTITUTED PHENYLALANINE DERIVATIVES
#3320Therapeutic compounds and uses thereof
#3321Indanyloxydihydrobenzofuranylacetic acids
#3322Therapeutically active compositions and their methods of use
#3323AMPK-activating heterocyclic compounds and methods for using the same
#3324Glucosylceramide synthase inhibitors for the treatment of diseases
#3325Cyanotriazole compounds
#3326Heterocyclic compounds for the inhibition of PASK
#3327TrkA kinase inhibitors, compositions and methods thereof
#3328C5AR antagonists
#3329GLP-1 receptor modulators
#33301,2- bis-sulfonamide derivatives as chemokine receptor modulators
#3331Heterocyclic compounds and uses thereof
#3332COMT inhibiting methods and compositions
#3333Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
#3334Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof
#3335Cytochrome P450 inhibitors and their method of use
#3336Pyridazinone compounds and uses thereof
#3337NITROGEN-CONTAINING SATURATED HETEROCYCLIC COMPOUND
#3338Therapeutically active compounds and their methods of use
#3339FUNGICIDAL COMPOSITIONS
#3340GLP-1 receptor modulators
#3341PRMT5 inhibitors and uses thereof
#3342Store overload-induced calcium release inhibitors and methods for producing and using the same
#3343Biaryl acyl-sulfonamide compounds as sodium channel inhibitors
#3344Triarylamine-substituted benzo[H]quinoline-derivatives as materials for electronic devices
#3345Lipids and compositions for the delivery of therapeutics
#3346Phenyl derivative
#3347Fungicidal pyrazoles
#3348AGRICULTURAL CHEMICALS
#3349HETEROCYCLIC COMPOUNDS AND USES THEREOF
#3350Crystalline forms of afatinib monomaleate, preparation methods and pharmaceutical compositions thereof
#3351Apelin receptor (APJ) agonists and uses thereof
#3352Antidiabetic tricyclic compounds
#3353Indol and indazol derivatives
#3354Aromatic compound and use thereof
#3355Anti-depression compounds
#3356Pro-neurogenic compounds
#3357Tetrazolinone compound and use of same
#3358N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetamide for control of agricultural/horticultural pests
#3359Carbazole-containing sulfonamides as cryptochrome modulators
#3360PROCESSES FOR PRODUCING CYCLOALKYLCARBOXAMIDO-PYRIDINE BENZOIC ACIDS
#3361Methods and compositions for selective and targeted cancer therapy
#3362Benzimidazolyl-methyl urea derivatives as ALX receptor agonists
#3363Substituted 1,2,3,4-tetrahydroisoquinoline derivatives for the treatment of hormone-dependent diseases
#3364Pharmaceutical Compositions for the Treatment of CFTR-Mediated Disorders
#3365Tetrahydrocyclopentapyrrole derivatives and a method for preparing the same
#3366Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic equipment
#3367Substituted benzene compounds
#3368Substituted nicotinamide derivatives as kinase inhibitors
#3369Compounds useful as immunomodulators
#3370Allosteric modulators of the cannabinoid 1 receptor
#3371Quinazolinones as bromodomain inhibitors
#3372Method for induction of a heat shock protein, anti-stress or regulation of an autonomic nerve
#3373Organic electroluminescence composition, material for organic electroluminescence element, solution of material for organic electroluminescence element, and organic electroluminescence element
#3374Bidentate-binding modulators of LRRK2 and JNK kinases
#3375ACC inhibitors and uses thereof
#3376N-cycloalkyl-N-[(fusedphenyl)methylene]-(thio)carboxamide derivatives
#3377Triazine derivative and pharmaceutical composition comprising the same
#3378Cyanoquinoline derivatives
#3379Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers
#3380Anthelmintic compounds and compositions and method of using thereof
#3381Autotaxin inhibitors
#3382Aminopyrimidine derivatives for use as modulators of kinase activity
#3383Compound, organic electroluminescent element material, organic electroluminescent element, and electronic device
#3384SUBSTITUTED PYRIDAZINE CARBOXAMIDE COMPOUNDS AS KINASE INHIBITOR COMPOUNDS
#3385Imidazolecarboxamides and their use as FAAH inhibitors
#3386Bifunctional compounds
#3387Inhibitors of ACK1/TNK2 tyrosine kinase
#3388Kinase inhibitors for the treatment of disease
#3389Aurora kinase inhibitors
#3390Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
#3391Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic equipment
#3392Myc modulators and uses thereof
#3393Compounds and methods for kinase modulation, and indications therefor
#3394COMPOSITIONS AND METHODS FOR MODULATING THE ACTIVITY OF EPSTEIN-BARR NUCLEAR ANTIGEN 1
#3395DI(HETERO)ARYLAMIDES AND SULFONAMIDES, METHODS FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF
#3396AUTOTAXIN INHIBITORS
#3397Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#3398Biaryl derivatives as GPR120 agonists
#3399Indole derivatives and their use in neurodegenerative diseases
#3400MODULATORS FOR ATP-BINDING CASSETTE TRANSPORTERS
#3401Fused tricyclic amide compounds as multiple kinase inhibitors
#3402Fused piperidine amides as modulators of ion channels
#3403N-cyclopropyl-N-piperidinyl-amides, pharmaceutical compositions containing them and uses thereof
#3404Piperazine derivatives as HIV protease inhibitors
#34052,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer
#3406Compounds for treatment of alzheimer's disease
#3407Substituted 6,5-fused bicyclic heteroaryl compounds
#34082,4-Diaminoquinazolines for Spinal Muscular Atrophy
#3409Pyridyl inhibitors of hedgehog signalling
#3410USE OF SELECTED PYRIDONE CARBOXAMIDES OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS
#3411Amine-based compounds and organic light-emitting devices comprising the same
#3412Aminomethyl-Biaryl Derivatives Complement Factor D inhibitors and uses thereof
#3413Protein tyrosine kinase modulators and methods of use
#3414Nitrogen-containing saturated heterocyclic compound
#34153-aryl propiolonitrile compounds for thiol labeling
#3416IDO inhibitors
#3417Materials for electronic devices
#3418Fluorogenic pH sensitive dyes and their method of use
#3419Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals
#3420Chromane and chromene derivatives and their use as CRAC modulators
#3421PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES
#3422BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE
#3423PRMT5 inhibitors and uses thereof
#3424Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof
#3425PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
#3426α-oxoacyl amino-caprolactam
#3427N-substituted azetidine derivatives
#3428Antibody drug conjugates
#3429Substituted quinazolines as receptor-type kinase inhibitors
#3430Indenoindole derivative and organic electroluminescent element
#3431INHIBITORS OF C-FMS KINASE
#3432Crystalline forms of afatinib di-maleate
#3433PRO-DRUG COMPOUNDS
#3434Bromodomain inhibitors
#3435Histone demethylase inhibitors
#3436Aromatic compounds with GPR40 agonistic activity
#3437Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
#3438α-Substituted glycinamide derivative
#3439POLYCYCLIC HERG ACTIVATORS
#3440Novel Cannabinergic Compounds and Uses Thereof
#3441CXCR7 receptor modulators
#3442Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof
#3443Pyruvate kinase activators for use in therapy
#3444Heterocyclic modulators of lipid synthesis
#3445Tubulin polymerization inhibitor and method for synthesizing same
#3446Indole-3-carboxamides as kinase inhibitors
#3447Kinase inhibitors
#3448Hydroxyindole carboxylic acid based inhibitors for oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)
#3449Indole-1-carboxamides as kinase inhibitors
#3450Tank-binding kinase inhibitor compounds
#3451Kinase inhibitor
#3452Substituted indazole derivatives active as kinase inhibitors
#3453Compositions and methods for treating metabolic disorders
#3454Neprilysin inhibitors
#3455ANTIBACTERIAL PHTHALIDE DERIVATIVES
#3456Estrogen receptor modulators and uses thereof
#3457Azetidine estrogen receptor modulators and uses thereof
#3458PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS
#3459Method for preparing Afatinib and intermediate thereof
#3460Neprilysin inhibitors
#3461Tricyclic sulphonamide compounds and methods of making and using same
#3462Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same
#3463Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
#3464Sulfur derivatives as chemokine receptor modulators
#3465ERK inhibitors and uses thereof
#3466Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C
#3467Tetrazolinone compound and use of same
#3468Condensed cyclic compound and organic light-emitting device including the same
#3469Synthesis of resorcylic acid lactones useful as therapeutic agents
#3470Benzoimidazol-1,2-yl amides as Kv7 channel activators
#3471Indazolyl- and indolyl-benzamide derivatives
#3472QUINOLINE AMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
#3473Modulators of cellular adhesion
#3474Pro-neurogenic compounds
#3475Analgesic compounds and methods of use
#3476Amidopyridinol derivative or pharmaceutically acceptable salt thereof and pharmaceutical composition comprising same as active component
#3477Compounds as diacylglycerol acyltransferase inhibitors
#3478Carbamate derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors
#3479Allosteric inhibitors of thymidylate synthase
#3480Aromatic amine derivatives and organic electroluminescent elements using same
#3481Substituted 6,6-Fused Nitrogenous Heterocyclic Compounds and Uses Thereof
#3482BROMODOMAIN INHIBITORS FOR TREATING DISEASE
#3483SUBSTITUTED BICYCLIC DIHYDROPYRIMIDINONES AND THEIR USE AS INHIBITORS OF NEUTROPHIL ELASTASE ACTIVITY
#3484AMINO-QUINOLINES AS KINASE INHIBITORS
#3485Strigolactam derivatives as plant growth regulating compounds
#3486RADIOLABELED GNRH ANTAGONISTS AS PET IMAGING AGENTS
#3487Casein kinase 1delta (CK1delta) inhibitors
#3488Intermediate of Ticagrelor and preparation method therefor, and preparation method for Ticagrelor
#3489NOVEL PYRIMIDINE AND PYRIDINE COMPOUNDS AND USAGE THEREOF
#3490Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
#3491Compositions and methods for cancer detection and treatment
#3492Compounds useful as antibiotic tolerance inhibitors
#3493Nitroso compounds as nitroxyl donors and methods of use thereof
#3494Piperazine-substituted benzothiophenes for treatment of mental disorders
#3495N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
#3496Fungicidal amides
#3497Substituted imidazo[1,2-d]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections
#3498Certain protein kinase inhibitors
#3499NRF2 SMALL MOLECULE INHIBITORS FOR CANCER THERAPY
#3500Heterocyclic derivative and pharmaceutical drug
#3501Inhibitors of c-fms kinase
#3502PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES
#3503Isoquinoline derivatives
#3504Factor XIa inhibitors
#3505THERAPEUTIC COMPOUNDS AND COMPOSITIONS
#3506Serotonin receptor modulators
#3507Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#3508CARM1 inhibitors and uses thereof
#3509DOSAGE UNITS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D] [1,3] DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID
#3510Analogues of epicatechin and related polyphenols
#3511Dihydroxy aromatic heterocyclic compound
#3512Pyrazolyl guanidine FF-ATPase inhibitors and therapeutic uses thereof
#3513Pyrazole indanyl carboxamides
#3514Oxindole compounds, solvent-free synthesis and use thereof
#3515Biaryl amide compounds as kinase inhibitors
#3516Substituted Benzene Compounds
#3517NAMPT and ROCK inhibitors
#3518Aromatic monomers deriving from glycerol units, process for their preparation and use thereof for the preparation of water-soluble conjugated polymers
#3519CYCLOALKYL-SUBSTITUTED PYRIMIDINEDIONE COMPOUNDS
#3520Substituted oxetanes and their use as inhibitors of cathepsin C
#3521Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
#3522Substituted dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
#3523Substituted hydroxamic acids and uses thereof
#3524Nampt Inhibitors
#3525Pyrimidinedione compounds
#3526Amine-based compound and organic light-emitting diode including the same
#3527Heterocyclic ring and carbocyclic derivative
#3528Process for preparing benzofuran-2-carboxamide derivatives
#3529Furanyl-imine and thiofuranyl-imine compounds for stabilizing ryanodine receptors from aberrant levels of calcium release
#3530Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto
#3531Pyrimidines as sodium channel blockers
#3532Pyrimidine and pyridine compounds and their usage
#3533Intermediates to prepare herbicidal pyrimidone derivatives
#3534Arginine methyltransferase inhibitors and uses thereof
#3535Arginine methyltransferase inhibitors and uses thereof
#3536Process for preparing benzofuran-2-carboxamide derivatives
#3537PPAR agonists
#3538Benzocycloalkenes as antifungal agents
#3539Aryl- or heteroaryl-substituted benzene compounds
#3540Benzamides
#3541Spliceostatin analogs and methods for their preparation
#3542Molecules having certain pesticidal utilities, intermediates, compositions, and processes, related thereto
#35435-hydroxytryptamine receptor 7 activity modulators and their method of use
#3544Indole and indazole compounds that activate AMPK
#3545Isoquinolines as potassium ion channel inhibitors
#3546PRO-DRUG COMPOUNDS
#3547Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals
#3548Dihydrobenzofuran derivatives as insecticidal compounds
#3549Neprilysin inhibitors
#3550Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors
#3551Benzo five-membered nitrogen heterocyclic piperidine or piperazine derivatives and preparation methods and pharmaceutical compositions thereof
#3552SUBSTITUTED PYRIDINE AND PYRAZINE COMPOUNDS AS PDE4 INHIBITORS
#3553Tricyclic compound and use thereof
#3554Antiviral compounds
#3555Substituted pyrazines as GPR40 agonists
#35562,4-pyrimidinediamine compounds and their uses
#35572,4-pyrimidinediamine compounds and their uses
#3558Pyrimidine carboxamides as sodium channel blockers
#3559Tau imaging probe
#3560Bicyclic compound, production and use thereof
#3561Macrocyclic picolinamides as fungicides
#3562Macrocyclic picolinamides as fungicides
#3563Therapeutic compounds and uses thereof
#3564ERK inhibitors and uses thereof
#3565Pyrimidine-2,4-diamine derivatives for treatment of cancer
#3566Neprilysin inhibitors
#3567Phthalazinone derivatives
#3568Antiviral compounds
#3569Compound, organic light emitting element comprising same, and display device comprising organic light emitting element
#3570Flap modulators
#3571Histone demethylase inhibitors
#3572SODIUM CHANNEL BLOCKERS
#3573N-prop-2-ynyl carboxamide derivatives and their use as TRPA1 antagonists
#3574Heteroaryl compounds and uses thereof
#3575Method for producing pyrazoles, novel pyrazoles and applications thereof
#3576FLAP modulators
#3577RADIOLABELED QUINAZOLINE DERIVATIVES
#3578Poly (ADP-ribose) polymerase inhibitor
#3579Labeled chemically reactive and biologically active comjugates, and methods and compositions thereof
#3580Compounds that modulate intracellular calcium
#3581Processes for preparing antiviral compounds
#3582Pyridine derivatives as soft rock inhibitors
#3583Methods of treating an overweight or obese subject
#3584Sulfoximine substituted quinazolines for pharmaceutical compositions
#3585PRMT5 inhibitors and uses thereof
#3586Amine-based compound and organic light-emitting device including the same
#3587Compounds for enzyme inhibition
#3588Phthalazinones and isoquinolinones as rock inhibitors
#3589Antiproliferative benzo [B] azepin-2-ones
#3590Aryl- or heteroaryl-substituted benzene compounds
#3591Mixed disulfide conjugates of thienopyridine compounds and uses thereof
#3592Conjugate compounds
#3593Substituted benzene compounds
#3594Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine
#35955- AND 6-MEMBERED HETEROCYCLIC COMPOUNDS
#3596Method for controlling arthropod pest
#3597METHODS OF INHIBITING PRMT5
#3598Procaspase activating compounds
#3599BET-PROTEIN-INHIBITING DIHYDROXYQUINOXALINONES
#3600Inhibitors of the USP1/UAF1 deubiquitinase complex and uses thereof